Dr Julian Sacre is a Senior Research Officer and Group Leader in the Clinical Diabetes and Epidemiology team at the Baker Institute. He completed his PhD at the University of Queensland (Cardiovascular Imaging Research Centre) before joining the Baker Institute for postdoctoral studies as a NHMRC Early Career Fellow (2014–17).

Dr Sacre is a chief investigator on the NHMRC-funded PREDICT study (Progression of Diabetic Complications) – a long-term cohort study dedicated to improving the prediction and prevention of diabetes complications. His primary area of expertise is in cardiovascular and kidney complications, where his focus is on better targeting of therapies to individuals most at risk. This includes optimising risk assessment for traditional complications such as vascular disease, as well as developing screening pathways for novel complications such as heart failure and atrial fibrillation. His work has received competitive funding from the National Heart Foundation, and has been recognised in national and international guidelines.

Dr Sacre is a member of the International Diabetes Federation (IDF) Diabetes Atlas Committee (2025, 2021; Undiagnosed Diabetes Special Interest Group), an investigator on population-level data linkage projects in Australia, and is involved in the Baker-led international collaboration to evaluate global trends in the incidence of diabetes, diabetes complications, and mortality (GLOBALDIAB).